BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


GE Healthcare launches IN Cell Analyzer Image Competition 2007: Win a trip to New York

Buckinghamshire, UK, 8th October 2007 – GE Healthcare has announced the launch of its annual IN Cell Analyzer Image Competition for 2007. The competition is supported by BioTechniques and invites all users of the IN Cell Analyzer system to submit three of their best images with a short description to incellimage@gehealthcare.com  by the 24th of November.

Two winners will be selected, one judged by a scientific panel and one by a popular vote on the website www.gehealthcare.com/incellcompetition  and by attendees at the CHI High Content Analysis meeting, San Francisco, next year in January. Winners will be announced at the meeting and will be awarded with a trip to New York together with their partner or colleague to see the images displayed on the NBC screen at Times Square on 7/9th March 2008.

The winning entries will be also displayed at the Conference of the Society for Biomolecular Sciences (SBS) in St. Louis in April 2008 and in the IN Cell Analyzer Image Calendar 2009.

Deadline for submitting the IN Cell Analyzer images is the 24th of November 2007.

For further information please contact:

Northbank Communications

Lorna Cuddon, Marc Egelhofer, Katie Odgaard

+44 (0)207 268 3002

gehealthcare@northbankcommunications.com

GE Healthcare

Nicola Simpson

+44 (0)1494 542 626

nicola.simpson@ge.com


About GE Healthcare’s IN Cell Analyzer

The IN Cell Analyzer represents a range of modular imaging systems for the fast and automated High Content Analysis (HCA). The advanced and highly sensitive platforms enable scientists to study cellular processes in their true biological context in research and drug discovery. They offer high-throughput microscopy in combination with modern cellular assays and robotic handling for automated cellular imaging and analysis. The IN Cell Analyzer provides the most versatile HCA portfolio on the market that is unique in its modularity, completeness and ease of use, and has been recognised with the 2007 Frost & Sullivan Technology Innovation Award.

About GE Healthcare:

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a US$17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.



 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.